Sara E Parli Selected Research

Sara E Parli Research Topics

3	Heart Arrest (Cardiac Arrest) 08/2022 - 04/2015
2	Critical Illness (Critically Ill) 08/2022 - 04/2015
2	Infections 05/2022 - 02/2018
2	Wounds and Injuries (Trauma) 02/2018 - 01/2018
1	Bradycardia 08/2022
1	Colonic Pseudo-Obstruction (Ogilvie Syndrome) 08/2022
1	Soft Tissue Infections 05/2022
1	Burns 02/2018
1	Sepsis (Septicemia) 02/2018
1	Ileus 01/2018
1	Fistula 01/2018
1	Pain (Aches) 01/2018
1	Frailty 11/2016
1	Atrial Fibrillation 01/2016
1	Hemorrhage 01/2016
1	Abdominal Pain (Pain, Abdominal) 01/2016
1	Stroke (Strokes) 01/2016
1	Intracranial Vasospasm 12/2015
1	AIDS-Related Complex (ARC) 12/2015
1	Brain Injuries (Brain Injury) 04/2015
1	Refeeding Syndrome 05/2014

2	Dexmedetomidine FDA Link 08/2022 - 04/2015
1	Neostigmine (Neostigmine Bromide)IBA 08/2022
1	Propofol (Diprivan)FDA LinkGeneric 08/2022
1	Atropine FDA LinkGeneric 08/2022
1	Hypnotics and Sedatives (Sedatives)IBA 08/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	ProcalcitoninIBA 02/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Dabigatran FDA Link 01/2016
1	CreatinineIBA 12/2015
1	Propranolol (Inderal)FDA LinkGeneric 04/2015
1	Morphine (MS Contin)FDA LinkGeneric 04/2015
1	Clonidine (ST 155)FDA LinkGeneric 04/2015
1	Suppositories (Vaginal Suppositories)IBA 04/2015
1	CarbohydratesIBA 05/2014
1	ElectrolytesIBA 05/2014
1	Glucose (Dextrose)FDA LinkGeneric 05/2014

2	Length of Stay 05/2022 - 01/2018
1	Intravenous Administration 08/2022
1	Debridement 05/2022
1	Duration of Therapy 02/2018
1	Pain Management 01/2018
1	Analgesia 01/2018
1	Activities of Daily Living (ADL) 11/2016
1	Continuous Renal Replacement Therapy 01/2016
1	Medication Errors (Medication Error) 01/2016